Role of the clinical laboratory in guiding treatment of Amanita virosa mushroom poisoning: report of two cases.
Historically, mortality after Amanita mushroom ingestion has ranged from 50% to 90%. Prompt diagnosis is imperative, and aggressive therapeutic measures must be instituted quickly to improve the outcome. We report successful treatment of two cases of A. virosa poisoning by use of combined therapies, including thioctic acid and hemoperfusion.
Piering
W F
WF
Department of Medicine, Medical College of Wisconsin, Froedtert Memorial Lutheran Hospital, Milwaukee 53226.
Bratanow
N
N
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000545:Amanita; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D002606:Charcoal / Q000627:therapeutic use; D005260:Female; D006464:Hemoperfusion; D006801:Humans; D008297:Male; D008875:Middle Aged; D009145:Mushroom Poisoning / Q000503:physiopathology / Q000628:therapy*; D010406:Penicillins / Q000627:therapeutic use; D011517:Prothrombin Time; D008063:Thioctic Acid / Q000627:therapeutic use
D010406:Penicillins; D002606:Charcoal; D008063:Thioctic Acid; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D001663:Bilirubin